Financials

Discussions Technicals Seasonals

372320 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Curocell, Inc. engages in the development of anticancer immune cell treatments. It specializes in CAR-T cell therapy. The company was founded by Gun-Soo Kim, Hyun-Bo Sim, and Chan-Hyuk Kim on December 1, 2016 and is headquartered in Daejeon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

372320 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company